Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Dan Theodorescu

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Living Beings

Procedures

Anatomy

Physiology

Chemicals & Drugs

Concepts & Ideas

Gene Expression Profiling

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Havaleshko Dmytro M; Smith Steven Christopher; Cho HyungJun; Cheon Sooyoung; Owens Charles R; Lee Jae K; Liotta Lance A; Espina Virginia; Wulfkuhle Julia D; Petricoin Emanuel F; Theodorescu Dan
Comparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer.
Williams Paul D; Cheon Sooyoung; Havaleshko Dmytro M; Jeong Hyeon; Cheng Feng; Theodorescu Dan; Lee Jae K
Concordant gene expression signatures predict clinical outcomes of cancer patients undergoing systemic therapy.
Pollard Courtney; Nitz Matt; Baras Alex; Williams Paul; Moskaluk Christopher; Theodorescu Dan
Genoproteomic mining of urothelial cancer suggests {gamma}-glutamyl hydrolase and diazepam-binding inhibitor as putative urinary markers of outcome after chemotherapy.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Dan Theodorescu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Havaleshko Dmytro M; Smith Steven Christopher; Cho HyungJun; Cheon Sooyoung; Owens Charles R; Lee Jae K; Liotta Lance A; Espina Virginia; Wulfkuhle Julia D; Petricoin Emanuel F; Theodorescu Dan
Comparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer.
Neoplasia (New York, N.Y.) 2009;11(11):1185-93.
2009: Williams Paul D; Cheon Sooyoung; Havaleshko Dmytro M; Jeong Hyeon; Cheng Feng; Theodorescu Dan; Lee Jae K
Concordant gene expression signatures predict clinical outcomes of cancer patients undergoing systemic therapy.
Cancer research 2009;69(21):8302-9.
2009: Pollard Courtney; Nitz Matt; Baras Alex; Williams Paul; Moskaluk Christopher; Theodorescu Dan
Genoproteomic mining of urothelial cancer suggests {gamma}-glutamyl hydrolase and diazepam-binding inhibitor as putative urinary markers of outcome after chemotherapy.
The American journal of pathology 2009;175(5):1824-30.
2009: Ehdaie Behfar; Stukenborg George J; Theodorescu Dan
Renal transplant recipients and patients with end stage renal disease present with more advanced bladder cancer.
The Journal of urology 2009;182(4):1482-7.
2009: Said N; Frierson H F; Chernauskas D; Conaway M; Motamed K; Theodorescu D
The role of SPARC in the TRAMP model of prostate carcinogenesis and progression.
Oncogene 2009;28(39):3487-98.
2009: Haubitz Marion; Good David M; Woywodt Alexander; Haller Hermann; Rupprecht Harald; Theodorescu Dan; Dakna Mohammed; Coon Joshua J; Mischak Harald
Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis.
Molecular & cellular proteomics : MCP 2009;8(10):2296-307.
2009: Slack-Davis Jill K; Hershey E Daniel; Theodorescu Dan; Frierson Henry F; Parsons J Thomas
Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate model.
Molecular cancer therapeutics 2009;8(8):2470-7.
2009: Schiffer Eric; Vlahou Antonia; Petrolekas Andreas; Stravodimos Konstantinos; Tauber Robert; Geschwend Jürgen E; Neuhaus Jochen; Stolzenburg Jens-Uwe; Conaway Mark R; Mischak Harald; Theodorescu Dan
Prediction of muscle-invasive bladder cancer using urinary proteomics.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(15):4935-43.
2009: Wu Yimin; Moissoglu Konstadinos; Wang Hong; Wang Xuejiao; Frierson Henry F; Schwartz Martin A; Theodorescu Dan
Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(14):5807-12.
2009: Moissoglu Konstadinos; McRoberts Kevin S; Meier Jeremy A; Theodorescu Dan; Schwartz Martin A
Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases.
Cancer research 2009;69(7):2838-44.
2009: Overdevest Jonathan B; Theodorescu Dan; Lee Jae K
Utilizing the molecular gateway: the path to personalized cancer management.
Clinical chemistry 2009;55(4):684-97.
2009: Smith Steven Christopher; Theodorescu Dan
Learning therapeutic lessons from metastasis suppressor proteins.
Nature reviews. Cancer 2009;9(4):253-64.
2009: Smith Steven Christopher; Nicholson Brian; Nitz Matthew; Frierson Henry F; Smolkin Mark; Hampton Garret; El-Rifai Wael; Theodorescu Dan
Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination.
The American journal of pathology 2009;174(2):371-9.
2009: Williams P D; Lee J K; Theodorescu D
Genomancy: predicting tumour response to cancer therapy based on the oracle of genetics.
Current oncology (Toronto, Ont.) 2009;16(1):56-8.
2009: Smith Steven Christopher; Theodorescu Dan
The Ral GTPase pathway in metastatic bladder cancer: key mediator and therapeutic target.
Urologic oncology 2009;27(1):42-7.
2009: Wu Zhong; Cho HyungJun; Hampton Garret M; Theodorescu Dan
Cdc6 and cyclin E2 are PTEN-regulated genes associated with human prostate cancer metastasis.
Neoplasia (New York, N.Y.) 2009;11(1):66-76.
2008: Wu Y; Siadaty M S; Berens M E; Hampton G M; Theodorescu D
Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration.
Oncogene 2008;27(52):6679-89.
2008: Schwartz Martin A; McRoberts Kevin; Coyner Matthew; Andarawewa Kumari L; Frierson Henry F; Sanders John M; Swenson Stephen; Markland Frank; Conaway Mark R; Theodorescu Dan
Integrin agonists as adjuvants in chemotherapy for melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(19):6193-7.
2008: Williams Paul D; Lee Jae K; Theodorescu Dan
Molecular credentialing of rodent bladder carcinogenesis models.
Neoplasia (New York, N.Y.) 2008;10(8):838-46.
2008: Theodorescu Dan
Cryotherapy for prostate cancer: what we know, what we need to know.
The Journal of urology 2008;180(2):437-8.
2008: Ehdaie Behfar; Theodorescu Dan
Predicting tumor outcomes in urothelial bladder carcinoma: turning pathways into clinical biomarkers of prognosis.
Expert review of anticancer therapy 2008;8(7):1103-10.
2008: Jones Randy A; Taylor Ann Gill; Bourguignon Cheryl; Steeves Richard; Fraser Gertrude; Lippert Marguerite; Theodorescu Dan; Mathews Holly; Kilbridge Kerry Laing
Family interactions among African American prostate cancer survivors.
Family & community health 2008;31(3):213-20.
2008: Wu Z; Gioeli D; Conaway M; Weber M J; Theodorescu D
Restoration of PTEN expression alters the sensitivity of prostate cancer cells to EGFR inhibitors.
The Prostate 2008;68(9):935-44.
2008: Smalley David M; Sheman Nicholas E; Nelson Kristina; Theodorescu Dan
Isolation and identification of potential urinary microparticle biomarkers of bladder cancer.
Journal of proteome research 2008;7(5):2088-96.
2008: Steeg Patricia S; Theodorescu Dan
Metastasis: a therapeutic target for cancer.
Nature clinical practice. Oncology 2008;5(4):206-19.
2008: Black Peter C; Brown Gordon A; Inamoto Teruo; Shrader Marissa; Arora Ameeta; Siefker-Radtke Arlene O; Adam Liana; Theodorescu Dan; Wu Xifeng; Munsell Mark F; Bar-Eli Menashe; McConkey David J; Dinney Colin P N
Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(5):1478-86.
2008: Schiffer Eric; Mischak Harald; Theodorescu Dan; Vlahou Antonia
Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform.
World journal of urology 2008;26(1):67-74.
2008: Ehdaie Behfar; Theodorescu Dan
Molecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosis.
Indian journal of urology : IJU : journal of the Urological Society of India 2008;24(1):61-7.
2008: Nitz Matthew D; Harding Michael A; Theodorescu Dan
Invasion and metastasis models for studying RhoGDI2 in bladder cancer.
Methods in enzymology 2008;439():219-33.
2007: Oxford G; Smith S C; Hampton G; Theodorescu D
Expression profiling of Ral-depleted bladder cancer cells identifies RREB-1 as a novel transcriptional Ral effector.
Oncogene 2007;26(50):7143-52.
2007: Bigler Dora; Gioeli Daniel; Conaway Mark R; Weber Michael J; Theodorescu Dan
Rap2 regulates androgen sensitivity in human prostate cancer cells.
The Prostate 2007;67(14):1590-9.
2007: Cho Hyungjun; Smalley David M; Theodorescu Dan; Ley Klaus; Lee Jae K
Statistical identification of differentially labeled peptides from liquid chromatography tandem mass spectrometry.
Proteomics 2007;7(20):3681-92.
2007: Herlevsen Mikael C; Theodorescu Dan
Mass spectroscopic phosphoprotein mapping of Ral binding protein 1 (RalBP1/Rip1/RLIP76).
Biochemical and biophysical research communications 2007;362(1):56-62.
2007: Theodorescu Dan; Mischak Harald
Mass spectrometry based proteomics in urine biomarker discovery.
World journal of urology 2007;25(5):435-43.
2007: Harding Michael A; Theodorescu Dan
RhoGDI2: a new metastasis suppressor gene: discovery and clinical translation.
Urologic oncology 2007;25(5):401-6.
2007: Lee Jae K; Havaleshko Dmytro M; Cho Hyungjun; Weinstein John N; Kaldjian Eric P; Karpovich John; Grimshaw Andrew; Theodorescu Dan
A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(32):13086-91.
2007: Smith Steven Christopher; Oxford Gary; Baras Alexander S; Owens Charles; Havaleshko Dmytro; Brautigan David L; Safo Martin K; Theodorescu Dan
Expression of ral GTPases, their effectors, and activators in human bladder cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(13):3803-13.
2007: Wu Z; McRoberts K S; Theodorescu D
The role of PTEN in prostate cancer cell tropism to the bone micro-environment.
Carcinogenesis 2007;28(7):1393-400.
2007: Herlevsen Mikael; Oxford Gary; Owens Charles R; Conaway Mark; Theodorescu Dan
Depletion of major vault protein increases doxorubicin sensitivity and nuclear accumulation and disrupts its sequestration in lysosomes.
Molecular cancer therapeutics 2007;6(6):1804-13.
2007: Flury Sarah C; Galgano Mary T; Mills Stacey E; Smolkin Mark E; Theodorescu Dan
Atypical small acinar proliferation: biopsy artefact or distinct pathological entity?
BJU international 2007;99(4):780-5.
2007: Ehdaie Behfar; Theodorescu Dan
Organ-sparing techniques for penile cancer: quo vadis?
Nature clinical practice. Urology 2007;4(4):182-3.
2007: Jones Randy A; Taylor Ann Gill; Bourguignon Cheryl; Steeves Richard; Fraser Gertrude; Lippert Marguerite; Theodorescu Dan; Mathews Holly; Kilbridge Kerry Laing
Complementary and alternative medicine modality use and beliefs among African American prostate cancer survivors.
Oncology nursing forum 2007;34(2):359-64.
2007: Havaleshko Dmytro M; Cho HyungJun; Conaway Mark; Owens Charles R; Hampton Garret; Lee Jae K; Theodorescu Dan
Prediction of drug combination chemosensitivity in human bladder cancer.
Molecular cancer therapeutics 2007;6(2):578-86.
2007: Wu Y; McRoberts K; Berr S S; Frierson H F; Conaway M; Theodorescu D
Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia.
Oncogene 2007;26(5):765-73.
2007: Herlevsen Mikael; Oxford Gary; Ptak Celeste; Shabanowitz Jeffrey; Hunt Donald F; Conaway Mark; Theodorescu Dan
A novel model to identify interaction partners of the PTEN tumor suppressor gene in human bladder cancer.
Biochemical and biophysical research communications 2007;352(2):549-55.
2006: Thomas Christopher Y; Theodorescu Dan
Collaboration of RON and epidermal growth factor receptor in human bladder carcinogenesis.
The Journal of urology 2006;176(5):1909-10.
2006: Thomas Christopher Y; Theodorescu Dan
Molecular markers of prognosis and novel therapeutic strategies for urothelial cell carcinomas.
World journal of urology 2006;24(5):565-78.
2006: Fletcher Sophie G; Mills Stacey E; Smolkin Mark E; Theodorescu Dan
Case-matched comparison of contemporary radiation therapy to surgery in patients with locally advanced prostate cancer.
International journal of radiation oncology, biology, physics 2006;66(4):1092-9.
2006: Rhee Jonathan J; Lebeau Sam; Smolkin Mark; Theodorescu Dan
Radical cystectomy with ileal conduit diversion: early prospective evaluation of the impact of robotic assistance.
BJU international 2006;98(5):1059-63.
2006: Moon Kihyuck; Theodorescu Dan
Does saturation biopsy improve prostate cancer detection?
Nature clinical practice. Urology 2006;3(9):468-9.
2006: Moon Kihyuck; Stukenborg George J; Keim Jessica; Theodorescu Dan
Cancer incidence after localized therapy for prostate cancer.
Cancer 2006;107(5):991-8.
2006: Rinker-Schaeffer Carrie W; O'Keefe James P; Welch Danny R; Theodorescu Dan
Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(13):3882-9.
2006: Copp Hillary L; Chin Joseph L; Conaway Mark; Theodorescu Dan
Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma.
Cancer 2006;107(1):60-6.
2006: Wu Z; Conaway M; Gioeli D; Weber M J; Theodorescu D
Conditional expression of PTEN alters the androgen responsiveness of prostate cancer cells.
The Prostate 2006;66(10):1114-23.
2006: Zürbig Petra; Renfrow Matthew B; Schiffer Eric; Novak Jan; Walden Michael; Wittke Stefan; Just Ingo; Pelzing Matthias; Neusüss Christian; Theodorescu Dan; Root Karen E; Ross Mark M; Mischak Harald
Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation.
Electrophoresis 2006;27(11):2111-25.
2006: Miller Nicole L; Theodorescu Dan
Status of robotic cystectomy in 2005.
World journal of urology 2006;24(2):180-7.
2006: Wu Z; Siadaty M S; Riddick G; Frierson H F; Lee J K; Golden W; Knuutila S; Hampton G M; El-Rifai W; Theodorescu D
A novel method for gene expression mapping of metastatic competence in human bladder cancer.
Neoplasia (New York, N.Y.) 2006;8(3):181-9.
2006: Theodorescu Dan; Wittke Stefan; Ross Mark M; Walden Michael; Conaway Mark; Just Ingo; Mischak Harald; Frierson Henry F
Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis.
The lancet oncology 2006;7(3):230-40.
2006: Smith Steven C; Oxford Gary; Wu Zhong; Nitz Matthew D; Conaway Mark; Frierson Henry F; Hampton Garret; Theodorescu Dan
The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer.
Cancer research 2006;66(4):1917-22.
2006: Keim Jessica L; Theodorescu Dan
Robot-assisted radical cystectomy in the management of bladder cancer.
TheScientificWorldJournal 2006;6():2560-5.
2005: Titus Brian; Frierson Henry F; Conaway Mark; Ching Keith; Guise Theresa; Chirgwin John; Hampton Garret; Theodorescu Dan
Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2.
Cancer research 2005;65(16):7320-7.
2005: Oxford Gary; Owens Charles R; Titus Brian J; Foreman Tonia L; Herlevsen Mikael C; Smith Steven C; Theodorescu Dan
RalA and RalB: antagonistic relatives in cancer cell migration.
Cancer research 2005;65(16):7111-20.
2005: Theodorescu Dan; Fliser Danilo; Wittke Stefan; Mischak Harald; Krebs Ronald; Walden Michael; Ross Mark; Eltze Elke; Bettendorf Olaf; Wulfing Christian; Semjonow Axel
Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine.
Electrophoresis 2005;26(14):2797-808.
2005: Copp Hillary; Bissonette Eric A; Theodorescu Dan
Tumor control outcomes of patients treated with trimodality therapy for locally advanced prostate cancer.
Urology 2005;65(6):1146-51.
2005: Miller Nicole; Smolkin Mark E; Bissonette Eric; Theodorescu Dan
Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
Cancer 2005;103(12):2499-506.
2005: Smith Steven C; Oxford Gary; Theodorescu Dan
The promise of gene-expression analysis in bladder cancer: a clinician's guide.
BJU international 2005;95(6):874-80.
2005: Fletcher Sophie G; Theodorescu Dan
Surgery or radiation: what is the optimal management for locally advanced prostate cancer?
The Canadian journal of urology 2005;12 Suppl 1():58-61; discussion 101-2.
2005: Koutrouvelis Panos G; Theodorescu Dan; Katz Stuart; Lailas Niko; Hendricks Fred
Brachytherapy of prostate cancer after colectomy for colorectal cancer: pilot experience.
The Journal of urology 2005;173(1):82-5; discussion 85-6.
2005: Titus Brian; Schwartz Martin A; Theodorescu Dan
Rho proteins in cell migration and metastasis.
Critical reviews in eukaryotic gene expression 2005;15(2):103-14.
2004: Nicholson Brian; Gulding Kathryn; Conaway Mark; Wedge Stephen R; Theodorescu Dan
Combination antiangiogenic and androgen deprivation therapy for prostate cancer: a promising therapeutic approach.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8728-34.
2004: Woolsey Jeffrey; Bissonette Eric; Schneider Bernard F; Theodorescu Dan
Prospective outcomes associated with migration from preoperative to intraoperative planned brachytherapy: a single center report.
The Journal of urology 2004;172(6 Pt 2):2528-31.
2004: Bradley Emily B; Bissonette Eric A; Theodorescu Dan
Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
BJU international 2004;94(7):1003-9.
2004: Nicholson Brian E; Frierson Henry F; Conaway Mark R; Seraj Jabed M; Harding Michael A; Hampton Garret M; Theodorescu Dan
Profiling the evolution of human metastatic bladder cancer.
Cancer research 2004;64(21):7813-21.
2004: Miller Nicole L; Theodorescu Dan
Health-related quality of life after prostate brachytherapy.
BJU international 2004;94(4):487-91.
2004: Gildea John J; Herlevsen Mikael; Harding Michael A; Gulding Kathryn M; Moskaluk Christopher A; Frierson Henry F; Theodorescu Dan
PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity.
Oncogene 2004;23(40):6788-97.
2004: Theodorescu Dan; Sapinoso L M; Conaway M R; Oxford G; Hampton G M; Frierson H F
Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3800-6.
2004: Theodorescu Dan; Frierson Henry F
When is a negative lymph node really negative? Molecular tools for the detection of lymph node metastasis from urological cancer.
Urologic oncology 2004;22(3):256-9.
2004: Bassignani Mtthew J; Moore Yan; Watson Laurence; Theodorescu Dan
Pilot experience with real-time ultrasound guided percutaneous renal mass cryoablation.
The Journal of urology 2004;171(4):1620-3.
2004: Makhlouf A A; Krupski T L; Kunkle D; Theodorescu D
The effect of sampling more cores on the predictive accuracy of pathological grade and tumour distribution in the prostate biopsy.
BJU international 2004;93(3):271-4.
2004: Nicholson Brian; Theodorescu Dan
Angiogenesis and prostate cancer tumor growth.
Journal of cellular biochemistry 2004;91(1):125-50.
2004: Theodorescu Dan
Cancer cryotherapy: evolution and biology.
Reviews in urology 2004;6 Suppl 4():S9-S19.
2004: Ames Caroline D; Frierson Henry F; Theodorescu Dan
Unusual case of recurrent low-grade invasive and endophytic squamous cell carcinoma of the penis.
Scandinavian journal of urology and nephrology 2004;38(3):258-9.
2003: Horwitz Eric M; Uzzo Robert G; Miller Nicole; Theodorescu Dan
Brachytherapy for prostate cancer: follow-up and management of treatment failures.
The Urologic clinics of North America 2003;30(4):737-50, viii-ix.
2003: Oxford Gary; Theodorescu Dan
The role of Ras superfamily proteins in bladder cancer progression.
The Journal of urology 2003;170(5):1987-93.
2003: Woolsey Jeffrey; Miller Nicole; Theodorescu Dan
Permanent interstitial brachytherapy for prostate cancer: a current review.
World journal of urology 2003;21(4):209-19.
2003: Theodorescu Dan; Pollack Alan
Radiation for prostate cancer issue.
World journal of urology 2003;21(4):189.
2003: Theodorescu Dan
Phosphoinositide signaling in urological disease.
The Journal of urology 2003;169(6):2394-6.
2003: Krupski Tracey; Bissonette Eric A; Petroni Gina R; Theodorescu Dan
The impact of prostate volume following neoadjuvant androgen deprivation on quality of life and voiding symptoms in patients undergoing permanent prostate brachytherapy.
European urology 2003;43(5):467-72.
2003: Hall J D; Bissonette E A; Boyd J C; Theodorescu D
Motivations and influences on the use of complementary medicine in patients with localized prostate cancer treated with curative intent: results of a pilot study.
BJU international 2003;91(7):603-7.
2003: Miller Nicole L; Bissonette Eric A; Bahnson Robert; Wilson John; Theodorescu Dan
Impact of a novel neoadjuvant and adjuvant hormone-deprivation approach on quality of life, voiding function, and sexual function after prostate brachytherapy.
Cancer 2003;97(5):1203-10.
2003: Bigler Dora; Gulding Kay M; Dann Roger; Sheabar Fayad Z; Conaway Mark R; Theodorescu Dan
Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action.
Oncogene 2003;22(8):1261-72.
2003: Hall Joshua D; Boyd James C; Lippert Marguerite C; Theodorescu Dan
Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey.
Urology 2003;61(2):402-7.
2003: Nicholson B; Theodorescu D
Molecular therapeutics in prostate cancer.
Histology and histopathology 2003;18(1):275-98.
2003: Theodorescu D
Molecular pathogenesis of urothelial bladder cancer.
Histology and histopathology 2003;18(1):259-74.
2003: Oxford Gary; Theodorescu Dan
Ras superfamily monomeric G proteins in carcinoma cell motility.
Cancer letters 2003;189(2):117-28.
2002: Harding Michael A; Arden Karen C; Gildea James W; Gildea John J; Perlman Elizabeth J; Viars Carrie; Theodorescu Dan
Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling.
Cancer research 2002;62(23):6981-9.
2002: Valicenti Richard K; Bissonette Eric A; Chen Chris; Theodorescu Dan
Longitudinal comparison of sexual function after 3-dimensional conformal radiation therapy or prostate brachytherapy.
The Journal of urology 2002;168(6):2499-504; discussion 2504.
2002: Gildea John J; Seraj M Jabed; Oxford Gary; Harding Michael A; Hampton Garret M; Moskaluk Christopher A; Frierson Henry F; Conaway Mark R; Theodorescu Dan
RhoGDI2 is an invasion and metastasis suppressor gene in human cancer.
Cancer research 2002;62(22):6418-23.
2002: Makhlouf Antoine A; Boyd James C; Chapman Terrence N; Theodorescu Dan
Perioperative costs and charges of prostate brachytherapy and prostatectomy.
Urology 2002;60(4):656-60.
2002: Coblentz Timothy R; Theodorescu Dan
Morbidity of modified prophylactic inguinal lymphadenectomy for squamous cell carcinoma of the penis.
The Journal of urology 2002;168(4 Pt 1):1386-9.
2002: Smith Emily B; Frierson Henry F; Mills Stacey E; Boyd James C; Theodorescu Dan
Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading?
Cancer 2002;94(8):2282-7.
2002: Chesson John P; Theodorescu Dan
Adrenal tumor with caval extension--case report and review of the literature.
Scandinavian journal of urology and nephrology 2002;36(1):71-3.
2002: Gildea John J; Harding Michael A; Seraj M Jabed; Gulding Kay M; Theodorescu Dan
The role of Ral A in epidermal growth factor receptor-regulated cell motility.
Cancer research 2002;62(4):982-5.
2002: Coblentz T R; Bissonette E A; Williams K R; Theodorescu D
Multimodality radiotherapy and androgen ablation in the treatment of clinically localized prostate cancer: early results in high risk patients.
Prostate cancer and prostatic diseases 2002;5(3):219-25.
2001: Sheta E A; Trout H; Gildea J J; Harding M A; Theodorescu D
Cell density mediated pericellular hypoxia leads to induction of HIF-1alpha via nitric oxide and Ras/MAP kinase mediated signaling pathways.
Oncogene 2001;20(52):7624-34.
2001: Chen C; Frierson H F; Haggerty P F; Theodorescu D; Gregory C W; Dong J T
An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
Genomics 2001;77(3):135-44.
2001: Santen R J; Petroni G R; Fisch M J; Myers C E; Theodorescu D; Cohen R B
Use of the aromatase inhibitor anastrozole in the treatment of patients with advanced prostate carcinoma.
Cancer 2001;92(8):2095-101.
2001: Theodorescu D; Older R A; Sorenson E J
Metastatic melanoma presenting as an ileal conduit filling defect.
The Journal of urology 2001;166(4):1393-4.
2001: Smith E; Yoon J; Theodorescu D
Evaluation of urinary continence and voiding function: early results in men with neo-urethral modification of the Hautmann orthotopic neobladder.
The Journal of urology 2001;166(4):1346-9.
2001: Bissonette E A; Fulmer B R; Petroni G R; Moul J W; Theodorescu D
Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men.
The Journal of urology 2001;166(4):1328-31; discussion 1331-2.
2001: Seraj M J; Thomas A R; Chin J L; Theodorescu D
Molecular determination of perivesical and lymph node metastasis after radical cystectomy for urothelial carcinoma of the bladder.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(6):1516-22.
2001: Fulmer B R; Bissonette E A; Petroni G R; Theodorescu D
Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma: comparison of radical prostatectomy to hormonobrachytherapy with and without external beam radiotherapy.
Cancer 2001;91(11):2046-55.
2001: Coblentz T R; Mills S E; Theodorescu D
Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
Cancer 2001;91(7):1284-90.
2001: Krupski T; Theodorescu D
Orthotopic neobladder following cystectomy: indications, management, and outcomes.
Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society / WOCN 2001;28(1):37-46.
2001: Nicholson B; Schaefer G; Theodorescu D
Angiogenesis in prostate cancer: biology and therapeutic opportunities.
Cancer metastasis reviews 2001;20(3-4):297-319.
2001: Karns L R; Kisielewski A; Gulding K M; Seraj J M; Theodorescu D
Manipulation of gene expression by an ecdysone-inducible gene switch in tumor xenografts.
BMC biotechnology 2001;1():11.
2001: Krupski T; Harding M A; Herce M E; Gulding K M; Stoler M H; Theodorescu D
The role of vascular endothelial growth factor in the tissue specific in vivo growth of prostate cancer cells.
Growth factors (Chur, Switzerland) 2001;18(4):287-302.
2000: Theodorescu D; Gillenwater J Y; Koutrouvelis P G
Prostatourethral-rectal fistula after prostate brachytherapy.
Cancer 2000;89(10):2085-91.
2000: Gardner T A; Bissonette E A; Petroni G R; McClain R; Sokoloff M H; Theodorescu D
Surgical and postoperative factors affecting length of hospital stay after radical prostatectomy.
Cancer 2000;89(2):424-30.
2000: Gildea J J; Harding M A; Gulding K M; Theodorescu D
Transmembrane motility assay of transiently transfected cells by fluorescent cell counting and luciferase measurement.
BioTechniques 2000;29(1):81-6.
2000: Sheta E A; Harding M A; Conaway M R; Theodorescu D
Focal adhesion kinase, Rap1, and transcriptional induction of vascular endothelial growth factor.
Journal of the National Cancer Institute 2000;92(13):1065-73.
2000: Krupski T; Moskaluk C; Boyd J C; Theodorescu D
A prospective pilot evaluation of urinary and immunohistochemical markers as predictors of clinical stage of urothelial carcinoma of the bladder.
BJU international 2000;85(9):1027-32.
2000: Krupski T; Petroni G R; Bissonette E A; Theodorescu D
Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer.
Urology 2000;55(5):736-42.
2000: Im D S; Heise C E; Harding M A; George S R; O'Dowd B F; Theodorescu D; Lynch K R
Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate.
Molecular pharmacology 2000;57(4):753-9.
2000: Gildea J J; Golden W L; Harding M A; Theodorescu D
Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer.
Genes, chromosomes & cancer 2000;27(3):252-63.
2000: Seraj M J; Harding M A; Gildea J J; Welch D R; Theodorescu D
The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines.
Clinical & experimental metastasis 2000;18(6):519-25.
1999: Lippert M C; McClain R; Boyd J C; Theodorescu D
Alternative medicine use in patients with localized prostate carcinoma treated with curative intent.
Cancer 1999;86(12):2642-8.
1999: Broder S R; Frierson H F; Theodorescu D
Unusual case of non-exophytic invasive penile squamous cell cancer arising from a chronic sinus tract.
Scandinavian journal of urology and nephrology 1999;33(5):333-5.
1999: Gray M; Petroni G R; Theodorescu D
Urinary function after radical prostatectomy: a comparison of the retropubic and perineal approaches.
Urology 1999;53(5):881-90; discussion 890-1.
1999: Theodorescu D; Frierson H F; Sikes R A
Molecular determination of surgical margins using fossa biopsies at radical prostatectomy.
The Journal of urology 1999;161(5):1442-8.
1999: Crane C H; Clark M M; Bissonette E A; Theodorescu D
Prospective evaluation of the effect of ionizing radiation on the bladder tumor-associated (BTA) urine test.
International journal of radiation oncology, biology, physics 1999;43(1):73-7.
1998: Theodorescu D; Laderoute K R; Calaoagan J M; Guilding K M
Inhibition of human bladder cancer cell motility by genistein is dependent on epidermal growth factor receptor but not p21ras gene expression.
International journal of cancer. Journal international du cancer 1998;78(6):775-82.
1998: Theodorescu D; Laderoute K R; Gulding K M
Epidermal growth factor receptor-regulated human bladder cancer motility is in part a phosphatidylinositol 3-kinase-mediated process.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1998;9(11):919-28.
1998: Theodorescu D; Balcom A; Smith C R; McLorie G A; Churchill B M; Khoury A E
Urethral replacement with vascularized tunica vaginalis: defining the optimal form of use.
The Journal of urology 1998;159(5):1708-11.
1998: Theodorescu D; Lippert M C; Broder S R; Boyd J C
Early prostate-specific antigen failure following radical perineal versus retropubic prostatectomy: the importance of seminal vesicle excision.
Urology 1998;51(2):277-82.
1998: Harding M A; Theodorescu D
Prognostic markers in localized prostate cancer: from microscopes to molecules.
Cancer metastasis reviews 1998;17(4):429-37.
1997: Theodorescu D; Broder S R; Boyd J C; Mills S E; Frierson H F
Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate.
Cancer 1997;80(11):2109-19.
1997: Lippert M C; Theodorescu D
The Hautmann neobladder with a chimney: a versatile modification.
The Journal of urology 1997;158(4):1510-2.
1997: Theodorescu D; Broder S R; Boyd J C; Mills S E; Frierson H F
p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate.
The Journal of urology 1997;158(1):131-7.
1997: Herrell S D; Trachtenberg J; Theodorescu D
Staging pelvic lymphadenectomy for localized carcinoma of the prostate: a comparison of 3 surgical techniques.
The Journal of urology 1997;157(4):1337-9.
1997: Lajvardi A; Theodorescu D; Older R A
A müllerian duct cyst presenting as a large complex pelvic mass.
The Journal of urology 1997;157(3):958.
1997: Frierson H F; Theodorescu D; Mills S E; Hanigan M H
gamma-Glutamyl transpeptidase in normal and neoplastic prostate glands.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1997;10(1):1-6.
1996: Theodorescu D
Prostate cancer--our patients' questions.
The Journal of urology 1996;155(5):1661-2.
1996: Theodorescu D; Russo P; Zhang Z F; Morash C; Fair W R
Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes.
The Journal of urology 1996;155(5):1626-31.
1996: Theodorescu D
Commentary on genetic prognostic markers for transitional cell carcinoma of the bladder: from microscopes to molecules.
The Journal of urology 1996;155(1):2.
1995: Huang F; Newman E; Theodorescu D; Kerbel R S; Friedman E
Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1995;6(12):1635-42.
1993: Theodorescu D; Connors K M; Groce A; Hoffman R M; Kerbel R S
Lack of influence of c-Ha-ras expression on the drug sensitivity of human bladder cancer histocultured in three-dimensions.
Anticancer research 1993;13(4):941-6.
1993: Schuh A C; Theodorescu D; Shalaby F; Breitman M L
Altered growth and spontaneous transformation of cells cultured from v-jun transgenic mice recapitulate wound-induced multistage tumorigenesis.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1993;4(3):177-84.
1993: Theodorescu D; Sheehan C; Kerbel R S
TGF-beta gene expression depends on tissue architecture.
In vitro cellular & developmental biology : journal of the Tissue Culture Association 1993;29A(2):105-8.
1992: Theodorescu D; Binnington A G; Connolly J G
The intestinoprostatic capsule anastomosis: functional and anatomic results in a canine model.
Canadian journal of surgery. Journal canadien de chirurgie 1992;35(2):169-72.
1992: Wu S P; Theodorescu D; Kerbel R S; Willson J K; Mulder K M; Humphrey L E; Brattain M G
TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector.
The Journal of cell biology 1992;116(1):187-96.
1991: Fu X Y; Theodorescu D; Kerbel R S; Hoffman R M
Extensive multi-organ metastasis following orthotopic onplantation of histologically-intact human bladder carcinoma tissue in nude mice.
International journal of cancer. Journal international du cancer 1991;49(6):938-9.
1991: Kerbel R S; Cornil I; Theodorescu D
Importance of orthotopic transplantation procedures in assessing the effects of transfected genes on human tumor growth and metastasis.
Cancer metastasis reviews 1991;10(3):201-15.
1991: Theodorescu D; Caltabiano M; Greig R; Rieman D; Kerbel R S
Reduction of TGF-beta activity abrogates growth promoting tumor cell-cell interactions in vivo.
Journal of cellular physiology 1991;148(3):380-90.
1991: Theodorescu D; Cornil I; Sheehan C; Man M S; Kerbel R S
Ha-ras induction of the invasive phenotype results in up-regulation of epidermal growth factor receptors and altered responsiveness to epidermal growth factor in human papillary transitional cell carcinoma cells.
Cancer research 1991;51(16):4486-91.
1991: Cornil I; Theodorescu D; Man S; Herlyn M; Jambrosic J; Kerbel R S
Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(14):6028-32.
1991: Cornil I; Theodorescu D; Kerbel R S; Poupon M F
[Metastatic dissemination of cancer cells]
Pathologie-biologie 1991;39(4):300-7.
1991: Theodorescu D; Cornil I; Sheehan C; Man S; Kerbel R S
Dominance of metastatically competent cells in primary murine breast neoplasms is necessary for distant metastatic spread.
International journal of cancer. Journal international du cancer 1991;47(1):118-23.
1991: Theodorescu D; Witchell S; Connolly J
Chronic adult renal vein thrombosis: two unusual cases and a review of the literature.
International urology and nephrology 1991;23(5):429-35.
1991: Theodorescu D; Bergsma D; Man M S; Elshourbagy N; Sheehan C; Rieman D; Kerbel R S
Cloning and overexpression of TGF-beta 1 cDNA in a mammary adenocarcinoma: in vitro and in vivo effects.
Growth factors (Chur, Switzerland) 1991;5(4):305-16.
1990: Theodorescu D; Cornil I; Fernandez B J; Kerbel R S
Overexpression of normal and mutated forms of HRAS induces orthotopic bladder invasion in a human transitional cell carcinoma.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(22):9047-51.
1990: Adams C; Theodorescu D; Murphy E G; Shandling B
Thymectomy in juvenile myasthenia gravis.
Journal of child neurology 1990;5(3):215-8.
1987: Blair G K; Filler R M; Theodorescu D
Neonatal pharyngoesophageal perforation mimicking esophageal atresia: clues to diagnosis.
Journal of pediatric surgery 1987;22(8):770-4.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Dan Theodorescu

Research Profile (preview)

Disorders

Living Beings

Procedures

Anatomy

Physiology

Chemicals & Drugs

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Dan Theodorescu (preview)

All Publications